ArticleBrazilian journal of veterinary medicine2026
Effect of buserelin acetate at artificial insemination on pregnancy per AI in dairy cows inseminated with sexed semen.
Article in Brazilian journal of veterinary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study determined whether administration of buserelin acetate (BA), a gonadotropin-releasing hormone agonist, during timed artificial insemination (TAI) improves pregnancy per AI (P/AI) of dairy cows inseminated with sexed semen. A total of 116 Girolando cows from three commercial dairy farms were randomly assigned to two treatment groups: Buserelin Group (BG; n = 58) that received 10 µg BA during AI, and Control Group (CG; n = 58) that did not receive an ovulation inducer. All animals were subjected to a standard ovulation-synchronization protocol, with AI performed 48 h after removing the progesterone device. Cyclicity status at the beginning of the protocol and preovulatory follicle (POF) diameter were included as covariates in statistical analysis. No significant difference in P/AI was observed between treatments (22.4% in BG vs. 13.8% in CG;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.